NICE guidance published today recommends leniolisib (also called Joenja and made by Pharming) for treating activated phosphoinositide 3-kinase delta syndrome (APDS) in people 12 years and over.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback